Silvia Caioli

IRCCS Neuromed, IS
Pozzilli, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Corrigendum to "Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement" [Brain, Behav., Immun. 135 (2026) 106523, ISSN 0889-1591].

Corrigendum to "Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement" [Brain, Behav., Immun. 135 (2026) 106523, ISSN 0889-1591].

Journal: Brain, behavior, and immunity

Published: August 12, 2026

T cells contribute to approaching positive but potentially risky stimuli through medial prefrontal cortex immune modulation.

T cells contribute to approaching positive but potentially risky stimuli through medial prefrontal cortex immune modulation.

Journal: Brain, behavior, and immunity

Published: January 11, 2026

Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement.

Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement.

Journal: Brain, behavior, and immunity

Published: August 04, 2025

Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis.

Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis.

Journal: Frontiers in molecular neuroscience

Published: May 09, 2024

Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis.

Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis.

Journal: Frontiers in immunology

Published: April 11, 2024

Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis.

Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis.

Journal: Journal of neuroinflammation

Published: February 09, 2024

Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis.

Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis.

Journal: Neuropharmacology

Published: December 06, 2023

MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis.

MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis.

Journal: Current neuropharmacology

Published: November 16, 2022

Synaptic and transcriptomic features of cortical and amygdala pyramidal neurons predict inefficient fear extinction.

Synaptic and transcriptomic features of cortical and amygdala pyramidal neurons predict inefficient fear extinction.

Journal: Cell reports

Published: October 14, 2022

Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis.

Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis.

Journal: Neurobiology of disease

Published: March 28, 2022

Transcriptomic and Network Analyses Reveal Immune Modulation by Endocannabinoids in Approach/Avoidance Traits.

Transcriptomic and Network Analyses Reveal Immune Modulation by Endocannabinoids in Approach/Avoidance Traits.

Journal: International journal of molecular sciences

Published: February 05, 2022

MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.

MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.

Journal: Neuropathology and applied neurobiology

Published: February 15, 2021

Showing 1-12 of 36

Last Updated: 09/26/2026